259 related articles for article (PubMed ID: 22674024)
1. Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.
Feng MG; Prieto MC; Navar LG
Am J Physiol Renal Physiol; 2012 Sep; 303(5):F775-82. PubMed ID: 22674024
[TBL] [Abstract][Full Text] [Related]
2. Interaction between endogenously produced carbon monoxide and nitric oxide in regulation of renal afferent arterioles.
Botros FT; Navar LG
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2772-8. PubMed ID: 16844915
[TBL] [Abstract][Full Text] [Related]
3. Lack of contribution of nitric oxide synthase to cholinergic vasodilation in murine renal afferent arterioles.
Park S; Bivona BJ; Harrison-Bernard LM
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1197-F1204. PubMed ID: 29412691
[TBL] [Abstract][Full Text] [Related]
4. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles.
Sobey CG; Faraci FM
Stroke; 1997 Apr; 28(4):837-42; discussion 842-3. PubMed ID: 9099205
[TBL] [Abstract][Full Text] [Related]
5. The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery.
Georgescu A; Pluteanu F; Flonta ML; Badila E; Dorobantu M; Popov D
Eur J Pharmacol; 2005 Jan; 508(1-3):159-66. PubMed ID: 15680267
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells.
Mollnau H; Schulz E; Daiber A; Baldus S; Oelze M; August M; Wendt M; Walter U; Geiger C; Agrawal R; Kleschyov AL; Meinertz T; Münzel T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):615-21. PubMed ID: 12692005
[TBL] [Abstract][Full Text] [Related]
7. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
Gupta S; Wright HM
Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol, a component of red wine, elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels.
Nagaoka T; Hein TW; Yoshida A; Kuo L
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4232-9. PubMed ID: 17724212
[TBL] [Abstract][Full Text] [Related]
9. Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.
Kakoki M; Hirata Y; Hayakawa H; Nishimatsu H; Suzuki Y; Nagata D; Suzuki E; Kikuchi K; Nagano T; Omata M
Hypertension; 1999 Jan; 33(1 Pt 2):467-71. PubMed ID: 9931149
[TBL] [Abstract][Full Text] [Related]
10. Contribution of nitric oxide, cyclic GMP and K+ channels to acetylcholine-induced dilatation of rat conduit and resistance arteries.
Woodman OL; Wongsawatkul O; Sobey CG
Clin Exp Pharmacol Physiol; 2000; 27(1-2):34-40. PubMed ID: 10696526
[TBL] [Abstract][Full Text] [Related]
11. Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo.
Sobey CG; Cocks TM
Stroke; 1998 Jul; 29(7):1439-44. PubMed ID: 9660401
[TBL] [Abstract][Full Text] [Related]
12. Neuronal nitric oxide synthase-dependent afferent arteriolar function in angiotensin II-induced hypertension.
Ichihara A; Imig JD; Navar LG
Hypertension; 1999 Jan; 33(1 Pt 2):462-6. PubMed ID: 9931148
[TBL] [Abstract][Full Text] [Related]
13. Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation.
Maffei A; Di Pardo A; Carangi R; Carullo P; Poulet R; Gentile MT; Vecchione C; Lembo G
Hypertension; 2007 Oct; 50(4):652-6. PubMed ID: 17664392
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the beta3 adrenoceptor in nebivolol-induced vasorelaxation in the rat aorta.
de Groot AA; Mathy MJ; van Zwieten PA; Peters SL
J Cardiovasc Pharmacol; 2003 Aug; 42(2):232-6. PubMed ID: 12883327
[TBL] [Abstract][Full Text] [Related]
15. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.
Jebelovszki E; Kiraly C; Erdei N; Feher A; Pasztor ET; Rutkai I; Forster T; Edes I; Koller A; Bagi Z
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2558-64. PubMed ID: 18408126
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells.
Ladage D; Brixius K; Hoyer H; Steingen C; Wesseling A; Malan D; Bloch W; Schwinger RH
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):720-4. PubMed ID: 16895546
[TBL] [Abstract][Full Text] [Related]
17. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
18. Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function.
Greven J; Gabriëls G
Arzneimittelforschung; 2000 Nov; 50(11):973-9. PubMed ID: 11148863
[TBL] [Abstract][Full Text] [Related]
19. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.
Dessy C; Saliez J; Ghisdal P; Daneau G; Lobysheva II; Frérart F; Belge C; Jnaoui K; Noirhomme P; Feron O; Balligand JL
Circulation; 2005 Aug; 112(8):1198-205. PubMed ID: 16116070
[TBL] [Abstract][Full Text] [Related]
20. The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i.
Cseplo P; Vamos Z; Ivic I; Torok O; Toth A; Koller A
PLoS One; 2016; 11(10):e0164010. PubMed ID: 27716772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
